Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) EBT: 2019-2024

Historic EBT for Burning Rock Biotech (BNR) over the last 6 years, with Dec 2024 value amounting to -$46.7 million.

  • Burning Rock Biotech's EBT fell 91.01% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.9 million, marking a year-over-year decrease of 107.19%. This contributed to the annual value of -$46.7 million for FY2024, which is 49.11% up from last year.
  • Burning Rock Biotech's EBT amounted to -$46.7 million in FY2024, which was up 49.11% from -$91.7 million recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's EBT ranged from a high of -$46.7 million in FY2024 and a low of -$140.5 million during FY2022.
  • Its 3-year average for EBT is -$93.0 million, with a median of -$91.7 million in 2023.
  • Its EBT has fluctuated over the past 5 years, first plummeted by 154.76% in 2020, then surged by 49.11% in 2024.
  • Yearly analysis of 5 years shows Burning Rock Biotech's EBT stood at -$62.4 million in 2020, then slumped by 100.09% to -$124.9 million in 2021, then fell by 12.53% to -$140.5 million in 2022, then skyrocketed by 34.72% to -$91.7 million in 2023, then surged by 49.11% to -$46.7 million in 2024.